Revolution Medicines (RVMD) reversed a lot of its recent rally on Monday after the Wall Street Journal reported that Merck (MRK) is no longer looking to buy the biotech firm. However, as George Tsilis explains, there may be more pressure pinning the stock beyond its potential missed acquisition story.
Market On Close
26 Jan 2026
SHARE